A Post-Marketing Observational Study to Evaluate the Effectiveness of Adalimumab in Patients With Moderately to Severely Active Rheumatoid Arthritis in China
Clinical trial NCT01464021 · TERMINATED
Trial details
- NCT number
- NCT01464021
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2011-12-01
- Primary completion
- 2012-12-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.